Atlas Trials

Study of High Dose Carfilzomib in Multiple Myeloma Patients Who Have Progressed On Standard Dose Carfilzomib

Clinical trial NCT01775553 · COMPLETED

Trial details

NCT number
NCT01775553
Sponsor
Ajai Chari
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Relapse Multiple MyelomaRefractory Multiple Myeloma
Start date
2013-09-01
Primary completion
2016-05-01
Enrollment
13

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.